Introduced
H. R. 9077
Introduced in House · June 6, 2026May 29, 2026
Ms. Scholten introduced the following bill; which was referred to the Committee on Energy and Commerce
A BILL
To direct the Director of the National Institutes of Health and the Secretary of Health and Human Services to evaluate hormone variability and hormone testing, respectively, in women with respect to perimenopause.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. Short title.
This Act may be cited as the “Hormone Health Data and Research Act”.